case_images: PMC5996646_01
case_images: Initial presentation with eczema and trophic changes of the surrounding skin
case_images: NJMS-9-78-g001.jpg
case_images: PMC5996646_01_NJMS-9-78-g001.jpg
case_images: F1
case_images: There was erythema, eczema, and trophic changes of the surrounding skin [Figure 1].
case_images: (a) Removal of reconstruction plate and primary closure and (b) ulcer 2 months postprimary closure
case_images: NJMS-9-78-g002.jpg
case_images: PMC5996646_01_NJMS-9-78-g002.jpg
case_images: F2
case_images: Previous treatment was with removal of exposed reconstruction plate and primary closure [Figure 2a]. Two-month later, the patient reported back with an ulcer on the same site [Figure 2b] which was bigger in size than the first reported.
case_images: (a) Calgigraf Silver foam and (b) Calgigraf foam dressing shaped to cover the wound
case_images: NJMS-9-78-g003.jpg
case_images: PMC5996646_01_NJMS-9-78-g003.jpg
case_images: F3
case_images: The failure of conventional methods of repeated wound dressings prompted the use of Calgigraf Ag foam [Figure 3a and b].
case_images: Significant decrease with granulation tissue formation after periodic Calgigraf foam dressing (day 45)
case_images: NJMS-9-78-g004.jpg
case_images: PMC5996646_01_NJMS-9-78-g004.jpg
case_images: F4
case_images: After a further 14 days [day 21] [Figure 4a and b], there was no longer any odor.
case_images: Complete healing day 60
case_images: NJMS-9-78-g005.jpg
case_images: PMC5996646_01_NJMS-9-78-g005.jpg
case_images: F5
case_images: Inflammation had decreased and the wound had reduced completely [Figure 5].